Patient-derived organoids: an emerging platform to de-risk immunotherapy development

Sylvia F Boj, Andrea Bisso

09 May 2023

Innovator Insight

Predicting patient response to immune-targeted therapies via interrogation of the tumor microenvironment

Mark Uhlik, Dr Caroline Fong

19 December 2022

Innovator Insight

Modulation of both tumor & T cell apoptosis to enhance CAR-T immunotherapy

Marco Ruella

19 December 2022

Innovator Insight

Advancing engineered cell & gene therapy with precision gene editing

John Lambourne

26 January 2022

Innovator Insight

Cell-based therapies for cancer treatment: leveraging advanced flow cytometry for greater clinical insight

11 October 2021

Innovator Insight

Overcoming purification challenges in antibody therapeutics manufacturing with subdomain-specific affinity solutions

Laurens Sierkstra

07 September 2021

Innovator Insight